Sight Sciences (SGHT) announced that UnitedHealthcare (UNH) has updated its Glaucoma Surgical Treatments policy to cover goniotomy, trabeculotomy, canaloplasty, and combined canaloplasty and trabeculotomy procedures for adults, when deemed medically necessary for treating mild to moderate open-angle glaucoma and cataract in adults currently being treated with ocular hypotensive medication. This coverage policy, effective October 1, 2025, applies to UHC’s commercial and individual exchange benefit plans. UHC is one of the largest health insurance companies in the United States with over 50 million total covered lives. The commercial and individual exchange benefits plans currently cover approximately 30 million of the over 50 million total covered lives under UHC.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SGHT:
- Sight Sciences: Hold Rating Amid Workforce Reduction and Cost Management Strategy
- Sight Sciences Announces Workforce Reduction Plan
- Sight Sciences price target raised to $4.50 from $3.60 at Citi
- Sight Sciences’ Earnings Call: Balancing Growth and Challenges
- Sight Sciences upgraded to Buy from Hold at Lake Street